At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 368 enrolled
Drug / intervention
AZD1981 +3 moredrug
Likely dose
AZD1981 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Randomised, Parallel Group, Multicentre Phase IIb, Placebo-Controlled, 1 Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids
In Brief
A Phase 2 clinical trial evaluating AZD1981 and Placebo for Asthma. Completed, enrolled 368 participants across 21 sites in 4 countries.
Detailed Summary
The primary objective of this study is to evaluate efficacy of AZD1981 in uncontrolled asthmatic patients on maintenance inhaled glucocorticosteroids.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesArgentina, Brazil, Costa Rica, Poland
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedSep 2008
Study CompletionJul 2009
TodayJul 2026
First PostedSep 25, 2008
Enrollment StartSep 1, 2008
Study CompletionJul 1, 2009
TodayJul 2, 2026
Posted 17.8 years ago
Interventions
AZD1981drug
Oral tablet, 50 mg twice daily
AZD1981drug
Oral tablet, 400 mg twice daily
AZD1981drug
Oral tablet, 1000 mg twice daily
Placebodrug